Browse our anti-SH3-Domain Kinase Binding Protein 1 (SH3KBP1) Antibodies

Full name:
anti-SH3-Domain Kinase Binding Protein 1 Antibodies (SH3KBP1)
On are 42 SH3-Domain Kinase Binding Protein 1 (SH3KBP1) Antibodies from 11 different suppliers available. Additionally we are shipping SH3-Domain Kinase Binding Protein 1 Proteins (9) and many more products for this protein. A total of 54 SH3-Domain Kinase Binding Protein 1 products are currently listed.
1200007H22Rik, 1700125L08Rik, 5830464D22Rik, AI447724, CD2BP3, CIN85, GIG10, HSB-1, HSB1, IN85, MIG18, Ruk, Seta
list all antibodies Gene Name GeneID UniProt
SH3KBP1 30011 Q96B97
SH3KBP1 58194 Q8R550
SH3KBP1 84357 Q925Q9

Show all species

Show all synonyms

Most Popular Reactivities for anti-SH3-Domain Kinase Binding Protein 1 (SH3KBP1) Antibodies

Select your species and application

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-SH3-Domain Kinase Binding Protein 1 Antibodies

Go to our pre-filtered search.

More Antibodies against SH3-Domain Kinase Binding Protein 1 Interaction Partners

Human SH3-Domain Kinase Binding Protein 1 (SH3KBP1) interaction partners

  1. these data support a role for the novel PP2Ac (show PPP2CA Antibodies)-CIN85 complex in supporting integrin-dependent platelet function by dampening the phosphatase activity.

  2. CIN85 promotes recycling of TGF-beta (show TGFB1 Antibodies) receptors and thereby positively regulates TGF-beta (show TGFB1 Antibodies) signaling.

  3. we demonstrate that SEPT9 (show SEPT9 Antibodies) negatively regulates EGFR (show EGFR Antibodies) degradation by preventing the association of the ubiquitin ligase Cbl (show CBL Antibodies) with CIN85, resulting in reduced EGFR (show EGFR Antibodies) ubiquitylation

  4. Results support the model that Cbl (show CBL Antibodies)-CIN85-endophilin complex is not required for efficient internalization of EGFR (show EGFR Antibodies), a prototype RTK.

  5. Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma cell line.

  6. LOX (show LOX Antibodies)-PP interacts with CIN85 via a novel SH3-binding motif and this association reduces CIN85-promoted invasion by breast cancer cells.

  7. an FRS2beta (show FRS3 Antibodies)-CIN85/CD2AP (show Cd2ap Antibodies)-Cbl (show CBL Antibodies) axis for downregulation of ErbB2 (show ERBB2 Antibodies) may regulate ErbB2 (show ERBB2 Antibodies) protein levels in physiological and pathological settings

  8. Data show that EGFR (show EGFR Antibodies) activation leads to a pronounced src (show SRC Antibodies)-mediated tyrosine phosphorylation of CIN85 that subsequently influences EGFR (show EGFR Antibodies) ubiquitination.

  9. this study indicates that high levels of Ruk(l)/CIN85 contribute to the conversion of breast adenocarcinoma cells into a more malignant phenotype via modulation of the Src (show SRC Antibodies)/Akt (show AKT1 Antibodies) pathway.

  10. Data show that CIN85 (c-Cbl interacting protein of 85 kDa) is constitutively associated with c-Cbl (show CBL Antibodies), Cbl-b, and B-cell linker (show BLNK Antibodies) in B cells.

Mouse (Murine) SH3-Domain Kinase Binding Protein 1 (SH3KBP1) interaction partners

  1. CIN85/RukL is involved in endocytosis of nephrin (show NPHS1 Antibodies) in podocytes under diabetic conditions, causing podocyte depletion and promoting proteinuria. CIN85/RukL expression therefore shows potential to be a novel target for antiproteinuric therapy in diabetes.

  2. Dab1 (show DAB1 Antibodies) mediated the association of CIN85 with ApoER2 (show LRP8 Antibodies) or VLDLR (show VLDLR Antibodies) in neurons.

  3. Data suggest that Ser587 Cin85 phosphomimetic mutant protein shows dramatically reduced binding to Dab1 (show DAB1 Antibodies) (disabled protein 1) (without affecting binding to CapZ (show CAPZA1 Antibodies)).

  4. Sh3kbp1 is SUMOylated by SUMO-1 (show SUMO1 Antibodies), -2, and -3 and that SUMOylation is enhanced in the presence of Cd2ap (show Cd2ap Antibodies).

  5. the interaction between SHIP-1 (show INPP5D Antibodies) and CIN85 might synergistically facilitate the down-regulation of phosphatidylinositol-3,4,5-trisphosphate levels.

  6. Live cell imaging and co-immunoprecipitation experiments confirmed that both SLP65 (show BLNK Antibodies) and CIN85 are both required for the onset and progression phases of B-cell antigen receptor signal transduction.

  7. a B cell-specific deletion of CIN85 led to impaired T cell-independent type II antibody responses in vivo and diminished IKK-beta (show IKBKB Antibodies) activation and cellular responses to B (show TDO2 Antibodies) cell receptor cross-linking in vitro

  8. Coexpression of CIN85/Ruk(L) with CD2AP (show Cd2ap Antibodies) led to a decreased binding of CIN85/Ruk(L) to nephrin (show NPHS1 Antibodies) and podocin, which indicates a functional competition between CD2AP (show Cd2ap Antibodies) and CIN85/Ruk(L).

  9. Data indicate an important function of CIN85 (SH3KBP1) in the regulation of dopamine D2 receptor (show DRD2 Antibodies) functions and provide a molecular explanation for the hyperactive behaviour of CIN85(Deltaex2) mice.

  10. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases

SH3-Domain Kinase Binding Protein 1 (SH3KBP1) Antigen Profile

Antigen Summary

This gene encodes an adapter protein that contains three N-terminal Src homology domains, a proline rich region and a C-terminal coiled-coil domain. The encoded protein facilitates protein-protein interactions and has been implicated in numerous cellular processes including apoptosis, cytoskeletal rearrangement, cell adhesion and in the regulation of clathrin-dependent endocytosis. Alternate splicing results in multiple transcript variants.

Alternative names and synonyms associated with SH3-Domain Kinase Binding Protein 1 (SH3KBP1)

  • SH3-domain kinase binding protein 1 (SH3KBP1) antibody
  • SH3-domain kinase binding protein 1 (sh3kbp1) antibody
  • SH3-domain kinase binding protein 1 (Sh3kbp1) antibody
  • 1200007H22Rik antibody
  • 1700125L08Rik antibody
  • 5830464D22Rik antibody
  • AI447724 antibody
  • CD2BP3 antibody
  • CIN85 antibody
  • GIG10 antibody
  • HSB-1 antibody
  • HSB1 antibody
  • IN85 antibody
  • MIG18 antibody
  • Ruk antibody
  • Seta antibody

Protein level used designations for SH3KBP1

SH3-domain kinase binding protein 1 , SH3 domain-containing kinase-binding protein 1-like , CD2-binding protein 3 , SH3 domain-containing kinase-binding protein 1 , Src family kinase-binding protein 1 , c-Cbl-interacting protein , cbl-interacting protein of 85 kDa , human Src family kinase-binding protein 1 , migration-inducing gene 18 , src-related kinase binding protein-1 , SH3-containing, expressed in tumorigenic astrocytes , Sh3 containing, expressed in astrocytes , regulator of ubiquitous kinase , SH3 domain-containing adapter protein , ruk

465527 Pan troglodytes
612797 Canis lupus familiaris
100013895 Monodelphis domestica
100058644 Equus caballus
100151706 Xenopus (Silurana) tropicalis
100357864 Oryctolagus cuniculus
100450340 Pongo abelii
100471577 Ailuropoda melanoleuca
694764 Macaca mulatta
100083478 Ornithorhynchus anatinus
100522530 Sus scrofa
100551401 Meleagris gallopavo
30011 Homo sapiens
58194 Mus musculus
84357 Rattus norvegicus
418608 Gallus gallus
510489 Bos taurus
Selected quality suppliers for anti-SH3-Domain Kinase Binding Protein 1 (SH3KBP1) Antibodies
Did you look for something else?